Exact Mass: 527.2452
Exact Mass Matches: 527.2452
Found 500 metabolites which its exact mass value is equals to given mass value 527.2452
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Hygromycin B
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents Hygromycin B is an aminoglycoside antibiotic active against prokaryotic and eukaryotic cells.
6-O-Carbamoylkanamycin A
A carbamoylkanamycin that is kanamycin A bearing a single carbamoyl substituent located at position 6 (on the 3-aminoglucose ring).
Hygromycin B
Hygromycin B is a fda approved antibiotic food additive for swine and poultry Hygromycin B is an antibiotic produced by the bacterium Streptomyces hygroscopicus. It is an aminoglycoside that kills bacteria, fungi and higher eukaryotic cells by inhibiting protein synthesis. In the laboratory it is used for the selection and maintenance of prokaryotic and eukaryotic cells that contain the hygromycin resistance gene. The resistance gene is a kinase that inactivates hygromycin B through phosphorylation. Since the discovery of hygromycin-resistance genes, hygromycin B has become a standard selection antibiotic in gene transfer experiments in many prokaryotic and eukaryotic cells D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents FDA approved antibiotic food additive for swine and poultry Hygromycin B is an aminoglycoside antibiotic active against prokaryotic and eukaryotic cells.
Rolitetracycline
Rolitetracycline is only found in individuals that have used or taken this drug. It is a pyrrolidinylmethyl tetracycline.Rolitetracycline is a semisynthetic broad-spectrum tetracycline antibiotic used especially for parenteral administration in cases requiring high concentrations or when oral administration is impractical. Rolitetracycline passively diffuses through porin channels in the bacterial membrane and reversibly binds to the 30S ribosomal subunit, preventing binding of tRNA to the mRNA-ribosome complex, and thus interfering with protein synthesis. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01A - Tetracyclines > J01AA - Tetracyclines C784 - Protein Synthesis Inhibitor > C1595 - Tetracycline Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic
Zosuquidar
(4S,4aS,5aS,6S,12aR)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-N-(pyrrolidin-1-ylmethyl)-4,4a,5,5a-tetrahydrotetracene-2-carboxamide
(1S*,3aS*,4S*,5S*,7S*,7aS*)-1-benzyloctahydro-5-hydroxy-4-[(1E,4S)-6-hydroxy-4,6-dimethyl-5,8-dioxooct-1-en-1-yl]-7-methyl-6-methylidene-3-oxo-3aH-isoindol-3a-yl methyl carbonate|cytochalasin Z19
(27R)-26,27-dihydro-virginiamycin-M1|(32R,6R,8E,13E,15E)-17t-hydroxy-6r-isopropyl-7c,15-dimethyl-5-oxa-11-aza-1(4,2)-oxazola-3(1,2)-pyrrolidina-cycloeicosaphane-8,13,15-triene-2,4,10,19-tetraone|23,35-ethane-1,2-diyl-madumycin-I|ostreogrycin-G|Pristinamycin|pristinamycin-IIB|virginiamycin-M2
Rolitetracycline
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01A - Tetracyclines > J01AA - Tetracyclines A derivative of tetracycline in which the amide function is substituted with a pyrrolidinomethyl group. C784 - Protein Synthesis Inhibitor > C1595 - Tetracycline Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic
Ala Phe Lys Tyr
Ala Phe Gln Tyr
Ala Phe Tyr Lys
Ala Phe Tyr Gln
Ala Lys Phe Tyr
Ala Lys Tyr Phe
Ala Gln Phe Tyr
Ala Gln Tyr Phe
Ala Tyr Phe Lys
Ala Tyr Phe Gln
Ala Tyr Lys Phe
Ala Tyr Gln Phe
Cys Phe Lys Met
Cys Phe Met Lys
Cys His Ile Arg
Cys His Leu Arg
Cys His Arg Ile
Cys His Arg Leu
Cys Ile His Arg
Cys Ile Arg His
Cys Lys Phe Met
Cys Lys Met Phe
Cys Leu His Arg
Cys Leu Arg His
Cys Met Phe Lys
Cys Met Lys Phe
Cys Arg His Ile
Cys Arg His Leu
Cys Arg Ile His
Cys Arg Leu His
Cys Arg Ser Tyr
Cys Arg Tyr Ser
Cys Ser Arg Tyr
Cys Ser Tyr Arg
Cys Tyr Arg Ser
Cys Tyr Ser Arg
Asp Glu His Lys
Asp Glu Lys His
Asp His Glu Lys
Asp His Lys Glu
Asp His Arg Thr
Asp His Thr Arg
Asp Lys Glu His
Asp Lys His Glu
Asp Arg His Thr
Asp Arg Thr His
Asp Thr His Arg
Asp Thr Arg His
Glu Asp His Lys
Glu Asp Lys His
Glu His Asp Lys
Glu His Lys Asp
Glu His Arg Ser
Glu His Ser Arg
Glu Lys Asp His
Glu Lys His Asp
Glu Pro Pro Trp
Glu Pro Trp Pro
Glu Arg His Ser
Glu Arg Ser His
Glu Ser His Arg
Glu Ser Arg His
Glu Trp Pro Pro
Phe Ala Lys Tyr
Phe Ala Gln Tyr
Phe Ala Tyr Lys
Phe Ala Tyr Gln
Phe Cys Lys Met
Phe Cys Met Lys
Phe Phe Lys Ser
Phe Phe Asn Thr
Phe Phe Gln Ser
Phe Phe Ser Lys
Phe Phe Ser Gln
Phe Phe Thr Asn
Phe His Pro Gln
Phe His Gln Pro
Phe Lys Ala Tyr
Phe Lys Cys Met
Phe Lys Phe Ser
Phe Lys Met Cys
Phe Lys Ser Phe
Phe Lys Tyr Ala
Phe Met Cys Lys
Phe Met Lys Cys
Phe Asn Phe Thr
Phe Asn Thr Phe
Phe Pro His Gln
Phe Pro Gln His
Phe Gln Ala Tyr
Phe Gln Phe Ser
Phe Gln His Pro
Phe Gln Pro His
Phe Gln Ser Phe
Phe Gln Tyr Ala
Phe Ser Phe Lys
Phe Ser Phe Gln
Phe Ser Lys Phe
Phe Ser Gln Phe
Phe Thr Phe Asn
Phe Thr Asn Phe
Phe Tyr Ala Lys
Phe Tyr Ala Gln
Phe Tyr Lys Ala
Phe Tyr Gln Ala
His Cys Ile Arg
His Cys Leu Arg
His Cys Arg Ile
His Cys Arg Leu
His Asp Glu Lys
His Asp Lys Glu
His Asp Arg Thr
His Asp Thr Arg
His Glu Asp Lys
His Glu Lys Asp
His Glu Arg Ser
His Glu Ser Arg
His Phe Pro Gln
His Phe Gln Pro
His Ile Cys Arg
His Ile Met Gln
His Ile Gln Met
His Ile Arg Cys
His Lys Asp Glu
His Lys Glu Asp
His Leu Cys Arg
His Leu Met Gln
His Leu Gln Met
His Leu Arg Cys
His Met Ile Gln
His Met Leu Gln
His Met Gln Ile
His Met Gln Leu
His Pro Phe Gln
His Pro Gln Phe
His Gln Phe Pro
His Gln Ile Met
His Gln Leu Met
His Gln Met Ile
His Gln Met Leu
His Gln Pro Phe
His Arg Cys Ile
His Arg Cys Leu
His Arg Asp Thr
His Arg Glu Ser
His Arg Ile Cys
His Arg Leu Cys
His Arg Ser Glu
His Arg Thr Asp
His Ser Glu Arg
His Ser Arg Glu
His Ser Val Trp
His Ser Trp Val
His Thr Asp Arg
His Thr Arg Asp
His Val Ser Trp
His Val Trp Ser
His Trp Ser Val
His Trp Val Ser
Ile Cys His Arg
Ile Cys Arg His
Ile His Cys Arg
Ile His Met Gln
Ile His Gln Met
Ile His Arg Cys
Ile Met His Gln
Ile Met Gln His
Ile Gln His Met
Ile Gln Met His
Ile Arg Cys His
Ile Arg His Cys
Lys Ala Phe Tyr
Lys Ala Tyr Phe
Lys Cys Phe Met
Lys Cys Met Phe
Lys Asp Glu His
Lys Asp His Glu
Lys Glu Asp His
Lys Glu His Asp
Lys Phe Ala Tyr
Lys Phe Cys Met
Lys Phe Phe Ser
Lys Phe Met Cys
Lys Phe Ser Phe
Lys Phe Tyr Ala
Lys His Asp Glu
Lys His Glu Asp
Lys Met Cys Phe
Lys Met Phe Cys
Lys Met Ser Tyr
Lys Met Tyr Ser
Lys Ser Phe Phe
Lys Ser Met Tyr
Lys Ser Tyr Met
Lys Tyr Ala Phe
Lys Tyr Phe Ala
Lys Tyr Met Ser
Lys Tyr Ser Met
Leu Cys His Arg
Leu Cys Arg His
Leu His Cys Arg
Leu His Met Gln
Leu His Gln Met
Leu His Arg Cys
Leu Met His Gln
Leu Met Gln His
Leu Gln His Met
Leu Gln Met His
Leu Arg Cys His
Leu Arg His Cys
Met Cys Phe Lys
Met Cys Lys Phe
Met Phe Cys Lys
Met Phe Lys Cys
Met His Ile Gln
Met His Leu Gln
Met His Gln Ile
Met His Gln Leu
Met Ile His Gln
Met Ile Gln His
Met Lys Cys Phe
Met Lys Phe Cys
Met Lys Ser Tyr
Met Lys Tyr Ser
Met Leu His Gln
Met Leu Gln His
Met Gln His Ile
Met Gln His Leu
Met Gln Ile His
Met Gln Leu His
Met Ser Lys Tyr
Met Ser Tyr Lys
Met Tyr Lys Ser
Met Tyr Ser Lys
Asn Phe Phe Thr
Asn Phe Thr Phe
Asn Thr Phe Phe
Pro Glu Pro Trp
Pro Glu Trp Pro
Pro Phe His Gln
Pro Phe Gln His
Pro His Phe Gln
Pro His Gln Phe
Pro Pro Glu Trp
Pro Pro Trp Glu
Pro Gln Phe His
Pro Gln His Phe
Pro Trp Glu Pro
Pro Trp Pro Glu
Gln Ala Phe Tyr
Gln Ala Tyr Phe
Gln Phe Ala Tyr
Gln Phe Phe Ser
Gln Phe His Pro
Gln Phe Pro His
Gln Phe Ser Phe
Gln Phe Tyr Ala
Gln His Phe Pro
Gln His Ile Met
Gln His Leu Met
Gln His Met Ile
Gln His Met Leu
Gln His Pro Phe
Gln Ile His Met
Gln Ile Met His
Gln Leu His Met
Gln Leu Met His
Gln Met His Ile
Gln Met His Leu
Gln Met Ile His
Gln Met Leu His
Gln Pro Phe His
Gln Pro His Phe
Gln Ser Phe Phe
Gln Tyr Ala Phe
Gln Tyr Phe Ala
Arg Cys His Ile
Arg Cys His Leu
Arg Cys Ile His
Arg Cys Leu His
Arg Cys Ser Tyr
Arg Cys Tyr Ser
Arg Asp His Thr
Arg Asp Thr His
Arg Glu His Ser
Arg Glu Ser His
Arg His Cys Ile
Arg His Cys Leu
Arg His Asp Thr
Arg His Glu Ser
Arg His Ile Cys
Arg His Leu Cys
Arg His Ser Glu
Arg His Thr Asp
Arg Ile Cys His
Arg Ile His Cys
Arg Leu Cys His
Arg Leu His Cys
Arg Ser Cys Tyr
Arg Ser Glu His
Arg Ser His Glu
Arg Ser Tyr Cys
Arg Thr Asp His
Arg Thr His Asp
Arg Tyr Cys Ser
Arg Tyr Ser Cys
Ser Cys Arg Tyr
Ser Cys Tyr Arg
Ser Glu His Arg
Ser Glu Arg His
Ser Phe Phe Lys
Ser Phe Phe Gln
Ser Phe Lys Phe
Ser Phe Gln Phe
Ser His Glu Arg
Ser His Arg Glu
Ser His Val Trp
Ser His Trp Val
Ser Lys Phe Phe
Ser Lys Met Tyr
Ser Lys Tyr Met
Ser Met Lys Tyr
Ser Met Tyr Lys
Ser Gln Phe Phe
Ser Arg Cys Tyr
Ser Arg Glu His
Ser Arg His Glu
Ser Arg Tyr Cys
Ser Val His Trp
Ser Val Trp His
Ser Trp His Val
Ser Trp Val His
Ser Tyr Cys Arg
Ser Tyr Lys Met
Ser Tyr Met Lys
Ser Tyr Arg Cys
Thr Asp His Arg
Thr Asp Arg His
Thr Phe Phe Asn
Thr Phe Asn Phe
Thr His Asp Arg
Thr His Arg Asp
Thr Asn Phe Phe
Thr Arg Asp His
Thr Arg His Asp
Val His Ser Trp
Val His Trp Ser
Val Ser His Trp
Val Ser Trp His
Val Trp His Ser
Val Trp Ser His
Trp Glu Pro Pro
Trp His Ser Val
Trp His Val Ser
Trp Pro Glu Pro
Trp Pro Pro Glu
Trp Ser His Val
Trp Ser Val His
Trp Val His Ser
Trp Val Ser His
Tyr Ala Phe Lys
Tyr Ala Phe Gln
Tyr Ala Lys Phe
Tyr Ala Gln Phe
Tyr Cys Arg Ser
Tyr Cys Ser Arg
Tyr Phe Ala Lys
Tyr Phe Ala Gln
Tyr Phe Lys Ala
Tyr Phe Gln Ala
Tyr Lys Ala Phe
Tyr Lys Phe Ala
Tyr Lys Met Ser
Tyr Lys Ser Met
Tyr Met Lys Ser
Tyr Met Ser Lys
Tyr Gln Ala Phe
Tyr Gln Phe Ala
Tyr Arg Cys Ser
Tyr Arg Ser Cys
Tyr Ser Cys Arg
Tyr Ser Lys Met
Tyr Ser Met Lys
Tyr Ser Arg Cys
Adenosine, N-acetyl-3,5-O-[1,1,3,3-tetrakis(1-Methylethyl)-1,3-disiloxanediyl]-
Zosuquidar
C1744 - Multidrug Resistance Modulator
SBC-115076
SBC-115076 is a potent proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor. PCSK9 is a proprotein convertase, which plays a crucial role in LDL receptor metabolism[1][2].
(E)-1-(5-((E)-(3-Fluorodibenzo(b,E)oxepin-11(6H)-ylidene)methyl)-1-((R)-1-morpholinopropan-2-yl)-1H-benzo(d)imidazol-2(3H)-ylidene)urea
Morpholine-4-carboxylic acid (1-(3-benzenesulfonyl-1-phenethylallylcarbamoyl)-3-methylbutyl)-amide
N-{3-[4-(3-Amino-propyl)-piperazin-1-YL]-propyl}-3-nitro-5-(galactopyranosyl)-beta-benzamide
N-{3-[4-(3-Amino-propyl)-piperazin-1-YL]-propyl}-3-nitro-5-(galactopyranosyl)-alpha-benzamide
(2S)-N-[(4S,4aR,6R,8S,8aR)-8-methoxy-7,7-dimethyl-6-[[(2R)-5-oxooxolan-2-yl]methyl]-4a,6,8,8a-tetrahydro-4H-pyrano[3,2-d][1,3]dioxin-4-yl]-2-hydroxy-2-[(2R,5R,6R)-2-methoxy-5,6-dimethyl-4-methylideneoxan-2-yl]acetamide
(1S,3R,4R)-3-ethyl-3,4,10,12-tetrahydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 2,3,6-trideoxy-3-(dimethylamino)-alpha-L-lyxo-hexopyranoside
[(2S,3R,4R,5R)-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[[(2S,3R)-3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl]oxy]-2-hydroxycyclohexyl]oxy-5-hydroxy-5-methyl-4-(methylamino)oxan-3-yl] dihydrogen phosphate
(3aS,4S,4R,5S,6R,7S,7aS)-4-[(1R,2S,3R,5S,6R)-3-amino-2,6-dihydroxy-5-(methylamino)cyclohexyl]oxy-6-[(1R)-1-amino-2-hydroxyethyl]-6-(hydroxymethyl)spiro[4,6,7,7a-tetrahydro-3aH-[1,3]dioxolo[4,5-c]pyran-2,2-oxane]-3,4,5,7-tetrol
Hygromycin B
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents Hygromycin B is an aminoglycoside antibiotic active against prokaryotic and eukaryotic cells.
N-[[(4R,5R)-8-(1-cyclohexenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-(3-pyridinyl)acetamide
N-[[(4R,5S)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-8-(4-methylpent-1-ynyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-(3-pyridinyl)acetamide
N-[[(4R,5R)-8-(1-cyclohexenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-(3-pyridinyl)acetamide
N-[[(4R,5R)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-8-(4-methylpent-1-ynyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-(3-pyridinyl)acetamide
N-[[(4S,5S)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-8-(4-methylpent-1-ynyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-(3-pyridinyl)acetamide
N-[[(4R,5S)-8-(1-cyclohexenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyridin-4-ylacetamide
N-[[(4R,5R)-8-(1-cyclohexenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyridin-4-ylacetamide
N-[[(4R,5S)-8-(1-cyclohexenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyridin-4-ylacetamide
N-[[(4S,5S)-8-(1-cyclohexenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyridin-4-ylacetamide
4-methoxy-N-[(5S,6R,9S)-5-methoxy-8-(2-methoxy-1-oxoethyl)-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
N-[[(4S,5S)-8-(1-cyclohexenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyridin-4-ylacetamide
4-methoxy-N-[(5S,6S,9R)-5-methoxy-8-(2-methoxyacetyl)-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
4-methoxy-N-[(5S,6S,9S)-5-methoxy-8-(2-methoxyacetyl)-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
4-methoxy-N-[(5R,6R,9S)-5-methoxy-8-(2-methoxy-1-oxoethyl)-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
N-[[(4S,5R)-8-(1-cyclohexenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyridin-4-ylacetamide
N-[[(4S,5R)-8-(1-cyclohexenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyridin-4-ylacetamide
N-[[(4R,5R)-8-(1-cyclohexenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyridin-4-ylacetamide
N-[[(4R,5S)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-8-(4-methylpent-1-ynyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-(3-pyridinyl)acetamide
N-[[(4S,5R)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-8-(4-methylpent-1-ynyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-(3-pyridinyl)acetamide
N-[[(4S,5R)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-8-(4-methylpent-1-ynyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-(3-pyridinyl)acetamide
N-[[(4S,5S)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-8-(4-methylpent-1-ynyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-(3-pyridinyl)acetamide
N-[[(4R,5R)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-8-(4-methylpent-1-ynyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-(3-pyridinyl)acetamide
N-[[(4S,5S)-8-(1-cyclohexenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-(3-pyridinyl)acetamide
4-methoxy-N-[(5R,6R,9R)-5-methoxy-8-(2-methoxy-1-oxoethyl)-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
4-methoxy-N-[(5S,6R,9R)-5-methoxy-8-(2-methoxy-1-oxoethyl)-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
4-methoxy-N-[(5R,6S,9R)-5-methoxy-8-(2-methoxy-1-oxoethyl)-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
2-[[(5S,6R,9R)-5-methoxy-14-[(2-methoxy-1-oxoethyl)amino]-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-8-yl]methyl]benzoic acid
N-[[(10R,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylethanesulfonamide
N-[[(10S,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylethanesulfonamide
(3R,6aS,8R,10aS)-8-[2-(cyclohexylmethylamino)-2-oxoethyl]-3-hydroxy-N-[4-(trifluoromethyl)phenyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide
[(1R)-2-[(3-fluorophenyl)-oxomethyl]-1-(hydroxymethyl)-7-methoxy-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]-phenylmethanone
alpha-L-Fucp-(1->3)-[4d-beta-D-Galp-(1->4)]-beta-D-GlcpNAc-OMe
2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-[(1,3-dihydroxy-2-pentyl-1-phenylpropan-2-yl)sulfanyl]ethyl}-C-hydroxycarbonimidoyl)butanoic acid
2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-[(2,3-dihydroxy-2-pentyl-1-phenylpropyl)sulfanyl]ethyl}-C-hydroxycarbonimidoyl)butanoic acid
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate
Antihelmycin
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents Hygromycin B is an aminoglycoside antibiotic active against prokaryotic and eukaryotic cells.
Destomysin
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents Hygromycin B is an aminoglycoside antibiotic active against prokaryotic and eukaryotic cells.
11-deoxy-beta-rhodomycin zwitterion
A zwitterion obtained by transfer of a proton from the 5-hydroxy to the tertiary amino group of 11-deoxy-beta-rhodomycin; major species at pH 7.3.
11-Deoxy-beta-rhodomycin
A member of the class of anthracyclines that is beta-rhodomycin lacking the phenolic hydroxy group at position 11.
Rapastinel (Trifluoroacetate)
Rapastinel Trifluoroacetate (GLYX-13 Trifluoroacetate) is an NMDA receptor modulator with glycine-site partial agonist properties. Rapastinel Trifluoroacetate has the potential for major depressive disorder treatment.